Skip to main content

Table 1 MSQoL-54 Physical and Mental scores in non-persistent, persistent, persistent non-adherent, and persistent adherent patients at baseline

From: Glatiramer acetate treatment persistence - but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: a prospective web-based patient-centred study (CAIR study)

 

MSQoL-54 Physical

Non-persistent (n = 70)

Persistent (n = 119)

Persistent non-adherent (n = 18)

Persistent adherent (n = 101)

Mean (SD)

(min.-max.)

49.5 (17.6)*

(13.0-91.5)

58.1 (16.9)*

(21.3-94.8)

55.5 (15.2)

(29.6-79.4)

58.6 (17.2)

(21.3-94.8)

 

MSQoL-54 Mental

 

Non-persistent (n = 74)

Persistent (n = 123)

Persistent non-adherent (n = 19)

Persistent adherent (n = 104)

Mean (SD)

(min.-max.)

55.9 (20.4)#

(21.2-94.4)

63.8 (16.8)#

(19.8-90.6)

61.7 (14.9)

(33.5-83.4)

64.2 (17.2)

(19.8-90.6)

  1. MSQoL-54, Multiple Sclerosis Quality of Life-54, min. minimum; max. maximum
  2. *P = 0.001; # P = 0.003